NYSE CRTR Economy Event Watch the replay →

Advertisement
Advertisement

LFSCvsPSCHETF Comparison

ETF 1
LFSC

F/m Emerald Life Sciences Innovation ETF

This fund is part of
Life Sciences
+2.91%
VS
ETF 2
PSCH

Invesco S&P SmallCap Health Care ETF

This fund is part of
US Health Care
+1.15%

F/m Emerald Life Sciences Innovation ETF (LFSC) belongs to the Life Sciences segment. Invesco S&P SmallCap Health Care ETF (PSCH) is part of the US Health Care segment. LFSC's top 3 sector exposures are Health Care and Sovereign. In contrast, PSCH's top sector exposures are Health Care  LFSC is more expensive with a Total Expense Ratio (TER) of 0.79%, versus 0.29% for PSCH. LFSC is up 8.38% year-to-date (YTD) with +$5M in YTD flows. PSCH performs worse with 8.34% YTD performance, and -$17M in YTD flows. Run a side-by-side ETF comparison of LFSC and PSCH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

LFSC vs PSCH performance and flow charts

Performance

-6.0-4.0-2.00.02.04.06.0%May 11May 18May 25Jun 1Jun 8

Cumulative Flows

01,000,0002,000,0003,000,000May 11May 18May 25Jun 1Jun 8

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 06/11/2026
1M3MYTD1Y3Y5Y
Perf.
LFSC
PSCH
+3.25%+6.29%
+13.25%+15.97%
+8.38%+8.34%
+60.86%+14.58%
n/a+7.93%
n/a-24.65%
Flows
LFSC
PSCH
+$352K+$492K
-$1M-$11M
+$5M-$17M
+$15M-$27M
--$150M
--$235M
Volatility and drawdown
3M1Y3Y5Y
Volatility
LFSC
PSCH
+30.50%+22.53%
+26.55%+20.59%
n/a+21.73%
n/a+22.89%
Max drawdown
LFSC
PSCH
-6.53%-4.81%
-16.25%-15.36%
n/a-22.80%
n/a-47.23%
Max drawdown duration
LFSC
PSCH
20d19d
168d168d
n/a477d
n/a1810d
Trading data

Create an account to view trading data

Join for free
LFSC
PSCH
Last sale
6/11/2026 at 7:14 PM
$39.91
$47.83
Previous close
06/11/2026
$38.58
$47.16
Consolidated volume
06/11/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of May 29, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

LFSC
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
LFSC
PSCH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 6/11/2026 at 7:14 PM
Live
Closed
LFSC
PSCH
Last price
$39.91
$47.83
1D performance
+3.45%
+1.42%
AuM$106.22 M$139.94 M
E/R0.79%0.29%
Characteristics
LFSC
PSCH
Management strategyActivePassive
ProviderEmerald GroupInvesco
Benchmark-S&P SmallCap 600 Capped Health Care Index
N° of holdings3371
Asset class-Equities
Trailing 12m distribution yield
Join
Join
Inception dateOctober 31, 2024April 7, 2010
ESGNoNo
Advertisement
Exposure

Countries

LFSC
USA
91.24%
Other
8.76%
PSCH
USA
96.15%
Other
3.85%

Sectors

LFSC
Health Care
73.79%
Other
26.21%
PSCH
Health Care
90.67%
Other
9.33%

Diversification

LFSC

Total weight of top 15 holdings out of 15

69.25%
PSCH

Total weight of top 15 holdings out of 15

44.63%

Top 15 holdings

Data as of April 30, 2026
LFSC
COGENT BIOSCIENCES
8.24%
TRAVERE THERAPEUTICS INC
6.94%
US00773J2024
6.56%
LIVANOVA
6.39%
MIRUM PHARMACEUTICALS INC
4.69%
UTD THERAPEUT
4.43%
US6402683063
4.39%
KALVISTA PHARMACEUTICALS INC
4.33%
GUARDANT HEALTH INC
3.94%
BRIDGEBIO PHARMA
3.81%
TRANSMEDICS GROUP
3.78%
SAVARA INC
3.34%
TREVI THERAPEUTICS
3.29%
US9229671048
2.75%
AXSOME THERA CMN STK
2.37%
PSCH
MOLINA HLTHCRE
4.96%
KRYSTAL BIOTECH INC
3.79%
GLAUKOS
3.77%
US10950A1060
3.46%
TELEFLEX
3.21%
PROTAGONIST THERAPEUTICS INC
3.11%
ALKERMES
3.00%
PTC THERAPEUTI/D
2.99%
TG THERAPEUTICS
2.59%
LIGAND PHARMACEUTICALS
2.56%
CORCEPT THERAPEUTICS
2.33%
US45579U1097
2.30%
APELLIS PHARMACEUTICALS
2.26%
RADNET
2.16%
MERIT MEDICAL SYSTEMS
2.15%
Frequently asked questions about LFSC and PSCH

How have the LFSC and PSCH ETFs performed in 2026?

As of June 11, 2026, LFSC is up 8.38% year-to-date (YTD), while PSCH has returned 8.34%. That puts LFSC better performer ahead so far this year.

Which ETF is attracting more investor money: LFSC or PSCH?

Year-to-date, the LFSC ETF saw +$5M in flows, compared to -$17M for PSCH.

Which ETF is more volatile: LFSC or PSCH?

Over the past year, LFSC had a volatility of 26.55%, while PSCH experienced 20.59%.

Which ETF is bigger: LFSC or PSCH?

As of June 11, 2026, LFSC holds $106.22 M in assets under management (AUM), while PSCH manages $139.94 M.

What sectors do the LFSC and PSCH ETFs invest in?

LFSC leans toward sectors like Health Care. Meanwhile, PSCH focuses on Health Care.

What are the top holdings of the LFSC ETF and PSCH ETF?

LFSC top holdings include COGENT BIOSCIENCES, TRAVERE THERAPEUTICS INC and US00773J2024. PSCH holds in its top three: MOLINA HLTHCRE, KRYSTAL BIOTECH INC and GLAUKOS.

Which ETF is more diversified: LFSC or PSCH?

LFSC holds 46 securities with 69.25% of its assets in the top 15. PSCH has 75 securities and a top 15 weight of 44.63%.

Advertisement
Advertisement
Advertisement
The Active Trader Report

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up

Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up